Michael A. Zasloff, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 25,000 shares at $47.53 ($1.2M) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Open-market sale of $1.2M AMPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.06 | 9,389 | $442K | 37.5% |
| 2 | $47.06 | 9,389 | $442K | 37.5% |
| 3 | $47.53 | 3,111 | $148K | 12.5% |
| 4 | $47.53 | 3,111 | $148K | 12.5% |
| Total | $47.18 avg | 25,000 | $1.2M | 100% |
| Filing → |
| AMPH | SELL | 2022-05-17 | $733K | — | Filing → |
| AMPH | SELL | 2022-03-17 | $337K | — | Filing → |
| AMPH | SELL | 2021-05-14 | $999K | — | Filing → |